Differences in pharmacokinetics and comparative bioavailability between premarin® and estratab® in healthy postmenopausal women
- 30 April 1994
- journal article
- Published by Elsevier in Current Therapeutic Research
- Vol. 55 (4) , 359-372
- https://doi.org/10.1016/s0011-393x(05)80521-1
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Comparison of estrogen productsAmerican Journal of Obstetrics and Gynecology, 1993
- Estratab, estratest, and premarin are not bioequivalentAmerican Journal of Obstetrics and Gynecology, 1993
- A comparison of circulating hormone levels in postmenopausal women receiving hormone replacement therapyAmerican Journal of Obstetrics and Gynecology, 1992
- Pharmacokinetics of oestrogens and progestogensMaturitas, 1990
- The Saga of the Ring B Unsaturated Equine Estrogens*Endocrine Reviews, 1988
- Transport of Equine Estrogens: Binding of Conjugated and Unconjugated Equine Estrogens with Human Serum Proteins*Journal of Clinical Endocrinology & Metabolism, 1985
- Pharmacology of conjugated oestrogensMaturitas, 1982
- Radioimmunoassay of Plasma Equilin and Estrone in Postmenopausal Women after the Administration of Premarin*Journal of Clinical Endocrinology & Metabolism, 1981
- PLASMA LEVELS OF OESTRONE, OESTRADIOL AND GONADOTROPHINS IN POSTMENOPAUSAL WOMEN AFTER ORAL AND VAGINAL ADMINISTRATION OF CONJUGATED EQUINE OESTROGENS (PREMARIN)BJOG: An International Journal of Obstetrics and Gynaecology, 1978
- Studies on Phenolic Steroids in Human Subjects. II. The Metabolic Fate and Hepato-Biliary-Enteric Circulation of C14-Estrone and C14-Estradiol in Women1Journal of Clinical Investigation, 1957